Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer

Karacin C., Sunar V., Urakci Z., YILMAZ A., Ayhan M., Ersoy M., et al.
Future oncology (London, England) , cilt.20, sa.4, ss.207-214, 2024 (SCI-Expanded) identifier identifier

Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia

AKTAŞ B. Y., ATA E. B., ÇEŞMECİ E., ÇAKIR İ. Y., Coşkunpınar M., TAHILLIOĞLU Y., et al.
Current Oncology , cilt.30, sa.11, ss.9689-9700, 2023 (SCI-Expanded) Creative Commons License identifier identifier

KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer

KUŞ F., Guven D. C., YILDIRIM H. Ç., Chalabiyev E., AKYILDIZ A., Tatar O. D., et al.
Biomarkers in Medicine , cilt.17, sa.7, ss.379-389, 2023 (SCI-Expanded) identifier identifier

Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy

GÜVEN D. C., Incesu F. G. G., YILDIRIM H. Ç., Erul E., Chalabiyev E., AKTAŞ B. Y., et al.
INTERNATIONAL JOURNAL OF CANCER , cilt.152, ss.679-685, 2023 (SCI-Expanded) identifier identifier identifier

Biochemical Response Evaluation on Lymphomas: Proposing a Scoring System

ERDAT E. C., ARIK Z., BARIŞTA İ.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.33, sa.3, ss.170-178, 2023 (SCI-Expanded) Creative Commons License identifier

Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards

GÜVEN D. C., EROĞLU İ., Ismayilov R., ULUSOYDAN E., AKTEPE O. H., TELLİ DİZMAN G., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.28, sa.8, ss.1807-1811, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Comparison of weekly methotrexate regimen versus methotrexate folinic acid 8-day regimen for treatment of low-risk gestational trophoblastic neoplasia

Korkmaz V., Sunar V., Akar S., Alinca C. M., ARIK Z., Boran N., et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , cilt.18, sa.3, ss.326-332, 2022 (SCI-Expanded) identifier identifier identifier

Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer

Sunar V., Korkmaz V., Topcu V., Cavdarli B., ARIK Z., Ozdal B., et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , cilt.18, sa.1, ss.84-92, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment

GÜRLER F., Ilhan A., GÜVEN D. C., TURHAN O., KURT İNCİ B., SÜTCÜOĞLU O., et al.
ANTI-CANCER DRUGS , cilt.33, sa.1, 2022 (SCI-Expanded) identifier identifier identifier

Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma

Gurler F., GÜVEN D. C., Aydemir E., SÜTCÜOĞLU O., Inci B. K., ARIK Z., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.5, ss.1559-1568, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality

GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., ÇEŞMECİ E., Incesu F. G. G., TAHILLIOĞLU Y., et al.
BMJ SUPPORTIVE & PALLIATIVE CARE , 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

Should Protocols Specific to Histologic Subtypes Be Applied in the Follow-Up of NSCLC?

ARIK Z., ERMAN M.
JOURNAL OF THORACIC ONCOLOGY , cilt.16, sa.10, 2021 (SCI-Expanded) Creative Commons License identifier identifier identifier

Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy

GÜVEN D. C., AKSUN M. S., ŞAHİN T. K., AKTEPE O. H., YILDIRIM H. Ç., TABAN H., et al.
SUPPORTIVE CARE IN CANCER , cilt.29, sa.9, ss.5417-5423, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

The prognostic significance of microsatellite status and its relationship with tumor-infiltrating lymphocyte in endometrial cancer

Lacin S., TAŞAR KAPAKLI G. E., USUBÜTÜN A., ARIK Z., YÜCE D., SALMAN M. C., et al.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , cilt.42, sa.3, ss.541-547, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical staging

GÜLTEKİN M., Guler O. C., Sari S., Yildirim B. A., Onal C., Celik H., et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY , cilt.41, sa.3, ss.414-420, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)

GÜLTEKİN M., AK S., AYHAN A., Strojna A., Pletnev A., Fagotti A., et al.
CANCER MEDICINE , cilt.10, sa.1, ss.208-219, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Comparison of Efficacies of Dose Dense Paclitaxel Plus Carboplatin and Conventional Paclitaxel Plus Carboplatin in the Treatment of Epithelial Ovarian Cancer

Sunar V., Korkmaz V., Aslan K., Kose C., Sarici F., ARIK Z., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.31, sa.4, ss.239-245, 2021 (SCI-Expanded) identifier identifier identifier

Defining the Optimal Regimen for Stage III Colon Cancer: Concerns with Study Design

GÜVEN D. C., GÜNER G., AKTAŞ B. Y., AKTEPE O. H., TABAN H., ARIK Z.
CLINICAL COLORECTAL CANCER , cilt.19, sa.3, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Efficacy of Pazopanib in patients with metastatic uterine sarcoma: A multi-institutional study

Sunar V., Korkmaz V., AKIN S., GÜVEN D. C., ARIK Z., Ates O., et al.
JOURNAL OF BUON , cilt.24, sa.6, ss.2327-2332, 2019 (SCI-Expanded) identifier identifier identifier

Retrospective Analysis of Gestational Trophoblastic Neoplasia: Single Center Experience

Sunar V., Korkmaz V., ARIK Z., Ozdal B., Engin Ustun Y.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.29, sa.3, ss.168-175, 2019 (SCI-Expanded) Creative Commons License identifier identifier

Cytoreductive Surgery for Intestinal Cancer Patients Metastatic to Ovaries Presenting as Primary Ovarian Cancer

Arik Z., Oz M., DİZDAR Ö., YILDIRIM M. E., OZGU E., TERZIOGLU S. G., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.2, ss.110-115, 2016 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

A systemic late recurrence after the first operation in a patient diagnosed with early-stage breast cancer: the latest recurrence in the literature

Keskin O. D., KERTMEN N., Karakas Y., BABACAN T., ARIK Z., Altundag K., et al.
JOURNAL OF BUON , cilt.20, sa.1, ss.348, 2015 (SCI-Expanded) identifier identifier identifier

Molecular subtypes in patients with inflammatory breast cancer; A single center experience

KERTMEN N., BABACAN T., Keskin O., Solak M., Sarici F., AKIN S., et al.
JOURNAL OF BUON , cilt.20, sa.1, ss.35-39, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale"

Kos F. T., Yazici O., Civelek B., Seker M., ARIK Z., AKSOY S., et al.
WIENER KLINISCHE WOCHENSCHRIFT , cilt.126, ss.36-41, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Association between common risk factors and molecular subtypes in breast cancer patients

Turkoz F. P., Solak M., Petekkaya I., Keskin O., KERTMEN N., Sarici F., et al.
BREAST , cilt.22, sa.3, ss.344-350, 2013 (SCI-Expanded) identifier identifier identifier

Demographic and clinico-pathological characteristics of breast cancer patients with history of oral alendronate use

Sendur M. A. N., Aksoy S., Yaman S., Arik Z., Ozdemir N. Y., Zengin N., et al.
MEDICAL ONCOLOGY , cilt.29, sa.4, ss.2601-2605, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Dermatomyositis complicated with a soft tissue sarcoma

Sendur M. A. N., Aksoy S., Yaman S., Arik Z., Kilinc L., Zengin N.
RHEUMATOLOGY INTERNATIONAL , cilt.32, sa.10, ss.3329-3330, 2012 (SCI-Expanded) identifier identifier identifier

Can all beta blockers improve the breast cancer survival?

Sendur M. A. N., Aksor S., Yaman S., Arik Z., Altundag K.
BREAST , cilt.21, sa.1, ss.107-108, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Is There an Association between Blood Group and Survival in Pancreatic Cancer?

Kos F. T., Civelek B., Seker M. M., ARIK Z., AKSOY S., Uncu D., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.12, ss.6151-6153, 2012 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Breast Cancer in a Patient with Agnogenic Myeloid Metaplasia

ARIK Z., OZKAN C., Ozdemir E., ALTUNDAG K.
SOUTHERN MEDICAL JOURNAL , cilt.103, sa.10, ss.1075-1076, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Diğer Dergilerde Yayınlanan Makaleler

Frontline Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Statement by the Africa Middle East Cancer Inter-group [AMCI]

Seoud M., Ladjeroud A., Jaafar H., Mokhtar M., Ozyilkan O., Alkhayyat S., et al.
Current Women's Health Reviews , cilt.20, sa.1, 2024 (ESCI) identifier

Comparison of Neoadjuvant Chemotherapy Plus Interval Debulking Surgery and Primary Debulking Surgery in Patients with Stage III and IV Ovarian Carcinoma: A Multicenter Real Life Experience

Yilmaz M., Başak M., Özyükseler D. T., Yildirim M. E., ARIK Z., SALMAN M. C., et al.
Turk Onkoloji Dergisi , cilt.38, sa.3, ss.323-332, 2023 (ESCI) Creative Commons License identifier

Leptomeningeal metastasis in primary uterine cervical cancer: a rare case and review of the literature

KAHVECİOĞLU A., Sari S. Y., YILDIRIM H. Ç., ARIK Z., GÜLTEKİN M., YILDIZ F.
Corrosion Science and Technology , cilt.19, sa.3, ss.184-189, 2023 (ESCI) Creative Commons License identifier

The impact of COVID-19 pandemic on nosocomial multidrug-resistant bacterial bloodstream infections and antibiotic consumption in a tertiary care hospital

Metan G., Cuha M. D., Hazirolan G., Dizman G. T., Tanriverdi E. S., Otlu B., et al.
GMS HYGIENE AND INFECTION CONTROL , cilt.17, 2022 (ESCI) Sürdürülebilir Kalkınma identifier identifier

Ovarian Carcinoma Presenting With a Large Cervical Mass

YILMAZ M. T., GÜRLEK E., GÜLTEKİN M., Kahraman K., SALMAN M. C., USUBÜTÜN A., et al.
CUREUS JOURNAL OF MEDICAL SCIENCE , cilt.14, sa.1, 2022 (ESCI) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Embedded outpatient palliative care service within the oncology clinic: Preliminary experience in Hacettepe Oncology Hospital

Guven D. C., AKTEPE O. H., Berk Z., Guner G., Taban H., AKTAŞ B. Y., et al.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30 identifier

Clinicopathologic features of BRCA mutated breast cancer patients: Hacettepe experience

AKSOY S., DEĞİRMENCİLER R. F., AKTAŞ B. Y., Guven D. C., AKTEPE O. H., Guner G., et al.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30 Sürdürülebilir Kalkınma identifier

Is microsatellite instability a negative prognostic factor in early stage endometrial cancer patients?

Lacin S., Tasar G. E., Usubutun A., Arik Z., Karakas Y., Yuce D., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37 Sürdürülebilir Kalkınma identifier

TRASTUZUMAB KARDİYOTOKSİSİTESİNİ İMMUNGLOBULİN /- STEROİD UYGULAMASI ÖNLEYEBİLİR Mİ?, TAVŞAN MODELİ HAYVAN DENEYİ

KERTMEN N., AKSOY S., ERMİŞ D. Y., KESKİN Ö., SOLAK M., ARIK Z., et al.
22. UKK, Türkiye, 19 - 23 Nisan 2017

Cytoreductive surgery for intestinal cancer patients metastatic to the adnexal presenting as primary ovarian cancer.

Arik Z., Dizdar O., Yildirim M. E., Ozgu E., Oz M., Terzioglu S. G., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33 Sürdürülebilir Kalkınma identifier

Which sequence prevents the heart from trastuzumab and anthracycline toxicity: Electron microscopy study in rats

Aksoy S., Kertmen N., ÜNER A., Sargon M., Ozkayar O., Keskin O., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32 identifier

Temporal changes in the survival of metastatic renal cell cancer patients and the impact of targeted agents: Single center experience

Erman M., Arik Z., Kilickap S., Bilen C. Y., Yazici S., Akdogan B., et al.
Genitourinary Cancers Symposium, San-Francisco, Kostarika, 30 Ocak - 01 Şubat 2014, cilt.32 Sürdürülebilir Kalkınma identifier

Arrhythmias during and after zoledronic acid infusion patients with bone metastasis.

Yazici O., Aksoy S., Ucar O., Ozdemir N., Demir M., Sendur M. A. N., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31 identifier

Clinicopathologic characteristics of pure papillary breast carcinoma

Turkoz F. P., Solak M., Keskin O., Arik Z., Arslan C., Kertmen N., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31 identifier

Inflammatory markers in metastatic breast cancer.

Sahin U., Petekkaya H., Gecmez G., Babacan T., Roach E. C., Sarici S. F., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31 Sürdürülebilir Kalkınma identifier

Variations of the ER, PR, and HER2 expression status according to operation day in breast cancer patients.

Arik Z., Aksoy S., Sendur M. A. N., Yaman S., Altundag K.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30 Sürdürülebilir Kalkınma identifier

Administration of contrast media just before the cisplatin-based chemotherapy increases the cisplatin-induced nephrotoxicity.

Sendur M. A. N., Aksoy S., Yaman S., Kos F. T., Arik Z., Civelek B., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30 identifier

Does total breastfeeding time influence the clinicopathologic characteristics and prognosis in breast cancer patients?

Yaman S., Aksoy S., Sendur M. A. N., Arik Z., Ozdemir N., Zengin N., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30 Sürdürülebilir Kalkınma identifier

Demographic and clinicopathologic characteristics of breast cancer patients with history of oral alendronate use

Aksoy S., Sendur M. A. N., Yaman S., Arik Z., Ozdemir N., Zengin N., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30 Sürdürülebilir Kalkınma identifier

Kitap & Kitap Bölümleri

Kastrasyona dirençli prostat kanseri tedavisi

ERMAN M., ARIK Z.
Üroonkoloji Kitabı, , Editör, Nobel, 2018

Metrikler

Yayın

51

Atıf (WoS)

127

H-İndeks (WoS)

5

Atıf (Scopus)

115

H-İndeks (Scopus)

6

Proje

8

Açık Erişim

13
BM Sürdürülebilir Kalkınma Amaçları